EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Fatty‐acid amide hydrolase inhibition mitigates Alzheimer's disease progression in mouse models of amyloidosis

Sergio Oddi iD, Lucia Scipioni, Antonio Totaro, Giacomo Giacovazzo, Francesca Ciaramellano iD, Daniel Tortolani, Alessandro Leuti, Rita Businaro, Federica Armeli, Andras Bilkei-Gorzo, Roberto Coccurello, Andreas Zimmer und 1 weitere

The FEBS Journal · 2025-08 · 292 (16) · 4160-4182

DOI: 10.1111/febs.17403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, online erschienen am 16.01.2025. Verfasst von Sergio Oddi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medicine, University of Teramo, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Amidohydrolases, Amyloidosis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministero dell'Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The endocannabinoid N ‐arachidonoylethanolamine (AEA) is a pro‐homeostatic bioactive lipid known for its anti‐inflammatory, anti‐oxidative, immunomodulatory, and neuroprotective properties, which may contrast/mitigate Alzheimer's disease (AD) pathology. This study explores the therapeutic potential of targeting fatty acid amide hydrolase (FAAH), the major enzyme degrading AEA, in mouse models of amyloidosis (APP/PS1 and Tg2576). Enhancing AEA signaling by genetic deletion of FAAH delayed cognitive deficits in APP/PS1 mice and improved cognitive symptoms in 12‐month‐old AD‐like mice. Chronic pharmacological FAAH inhibition fully reverted neurocognitive decline, attenuated neuroinflammation, and promoted neuroprotective mechanisms in Tg2576 mice. Additionally, pharmacological FAAH inhibition robustly suppressed β‐amyloid production and accumulation, associated with decreased expression of β‐site amyloid precursor protein cleaving enzyme 1 (BACE1), possibly through a cannabinoid receptor 1‐dependent epigenetic mechanism. These findings improve our understanding of AEA signaling in AD pathogenesis and provide proof of concept that selective targeting of FAAH activity could be a promising therapeutic strategy against AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmidohydrolasesAmyloidosisAnimalsMiceDisease Models, AnimalMice, TransgenicAmyloid Precursor Protein SecretasesAmyloid beta-Protein PrecursorDisease ProgressionAspartic Acid EndopeptidasesAmyloid beta-PeptidesEndocannabinoidsHumansArachidonic AcidsPolyunsaturated AlkamidesMaleFatty Acid Amide Hydrolases

Stichwörter der Autor:innen

APP/PS1Alzheimer's diseaseN‐arachidonoylethanolamineTg2576amyloidogenic mouse modelsfatty acid amide hydrolaseβ‐site amyloid precursor protein cleaving enzyme 1

Substanzen

AmidohydrolasesAmyloid Precursor Protein SecretasesAmyloid beta-Protein PrecursorAspartic Acid EndopeptidasesAmyloid beta-PeptidesEndocannabinoidsArachidonic AcidsPolyunsaturated AlkamidesFatty Acid Amide HydrolasesBace1 protein, mouse

Autor:innen und Institutionen

  • Department of Veterinary Medicine, University of Teramo, Italy.
  • European Center for Brain Research/Institute for Research and Health Care (IRCCS) Santa Lucia Foundation, Rome, Italy.
  • Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Italy.
  • Department of Pharmacy - Pharmaceutical Sciences, University of Bari "Aldo Moro", Bari, Italy.
  • Department of Medicine, Campus Bio-Medico University of Rome, Italy.
  • Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.

ORCID-Profile: Sergio Oddi, Francesca Ciaramellano

Förderung

  • Ministero dell'Università e della Ricerca

Zitieren

APA

Oddi, S., Scipioni, L., Totaro, A., Giacovazzo, G., Ciaramellano, F., Tortolani, D., Leuti, A., Businaro, R., Armeli, F., Bilkei-Gorzo, A., Coccurello, R., Zimmer, A., & Maccarrone, M. (2025). Fatty‐acid amide hydrolase inhibition mitigates Alzheimer's disease progression in mouse models of amyloidosis. The FEBS Journal, 292(16), 4160-4182. https://doi.org/10.1111/febs.17403

Vancouver

Oddi S, Scipioni L, Totaro A, Giacovazzo G, Ciaramellano F, Tortolani D, et al. Fatty‐acid amide hydrolase inhibition mitigates Alzheimer's disease progression in mouse models of amyloidosis. The FEBS Journal. 2025;292(16):4160-4182. doi:10.1111/febs.17403

BibTeX
@article{Oddi2025,
  author = {Oddi, Sergio and Scipioni, Lucia and Totaro, Antonio and Giacovazzo, Giacomo and Ciaramellano, Francesca and Tortolani, Daniel and Leuti, Alessandro and Businaro, Rita and Armeli, Federica and Bilkei-Gorzo, Andras and Coccurello, Roberto and Zimmer, Andreas and Maccarrone, Mauro},
  title = {Fatty‐acid amide hydrolase inhibition mitigates Alzheimer's disease progression in mouse models of amyloidosis},
  journal = {The FEBS Journal},
  year = {2025},
  volume = {292},
  number = {16},
  pages = {4160--4182},
  doi = {10.1111/febs.17403}
}
Kostenlos starten →